Business
Philips delivers on Q1 results, with ongoing order intake growth
May 6, 2025Q1 2025 Group performance Group sales EUR 4.1 billion, reflecting a 2% decline in comparable sales growth mainly due to China; slightly ahead of company outlook due to Personal Health growth and royalty phasingComparable order intake increased 2% despite China declineIncome from operations increased to EUR 154 millionAdjusted EBITA margin declined 80 bps to 8.6% of sales, driven by sales phasingFree cash outflow of EUR 1,091 million included EUR 1,025 million payment for Philips Respi
About this update from Koninklijke Philips N.v.
[{"type":"image","alt":"Royal Philips","displaySize":"","headline":null,"caption":"Royal Philips","className":"","disableSlideshowImg":false,"size":{"original":{"width":300,"height":55,"url":"https://media.zenfs.com/en/globenewswire.com/e89b2492268f247076ffcde3cdf98919"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/gAicZ00NXenNt1pULlYKVg--/YXBwaWQ9aGlnaGxhbmRlcjt3PTQyMDtoPTc3O2NmPXdlYnA-/https://media.zenfs.com/en/globenewswire.com/e89b2492268f247076ffcde3cdf98919","width":300,"height":55}},"lazy":false},{"type":"text","content":"May 6, 2025Q1 2025 Group performance","length":39,"tagName":"p"},{"type":"list","items":[{"val":[{"type":"text","content":"Group sales EUR 4.1 billion, reflecting a 2% decline in comparable sales growth mainly due to China; slightly ahead of company outlook due to Personal Health growth and royalty phasing","length":184,"tagName":"p"}]},{"val":[{"type":"text","content":"Comparable order intake increased 2% despite China decline","length":58,"tagName":"p"}]},{"val":[{"type":"text","content":"Income from operations increased to EUR 154 million","length":51,"tagName":"p"}]},{"val":[{"type":"text","content":"Adjusted EBITA margin declined 80 bps to 8.6% of sales, driven by sales phasing","length":79,"tagName":"p"}]},{"val":[{"type":"text","content":"Free cash outflow of EUR 1,091 million included EUR 1,025 million payment for Philips Respironics recall-related medical monitoring and personal injury settlements in US","length":169,"tagName":"p"}]},{"val":[{"type":"text","content":"Updated full year 2025 outlook for Adjusted EBITA margin and free cash flow; sales outlook remains unchanged","length":108,"tagName":"p"}]}],"tagName":"ul","bulletedList":true,"length":649,"olType":false},{"type":"text","content":"Roy Jakobs, CEO of Royal Philips:“We remain dedicated to serving our customers, driving profitable growth and delivering better care for more people. Our order intake growth continued with strong momentum particularly in the US, coupled with positive growth in personal health, providing an encouraging start to the year.In an uncertain macro environment that has intensified due to the potential impact of tariffs, we are focused on what we can control. We are improving our supply chain agility, taking decisive cost actions to mitigate financial impact where possible, and ensuring we can continue to serve our customers and cons...